Sterotherapeutics begins Phase II trial for ST-002 targeting Cushing’s Syndrome
US-based clinical-stage company Sterotherapeutics has announced the commencement of a Phase II clinical trial for its drug candidate, ST-002, for ...
US-based clinical-stage company Sterotherapeutics has announced the commencement of a Phase II clinical trial for its drug candidate, ST-002, for ...
Wellness360 by Dr. Garg delivers the latest health news and wellness updates—curated from trusted global sources. We simplify medical research, trends, and breakthroughs so you can stay informed without the overwhelm. No clinics, no appointments—just reliable, doctor-reviewed health insights to guide your wellness journey